Page last updated: 2024-11-06

methylallyl trisulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methylallyl trisulfide: platelet aggregation inhibitor in garlic [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID61926
SCHEMBL ID534079
MeSH IDM0091728

Synonyms (29)

Synonym
1-allyl-3-methyltrisulfane
trisulfide, methyl 2-propenyl
methyl allyl trisulfide
fema no. 3253
ccris 3265
allyl methyl trisulphide
allyl methyl trisulfide
methyl 2-propenyl trisulfide
trisulfide, allyl methyl
methylallyl trisulfide
einecs 251-843-8
3-(methyltrisulfanyl)prop-1-ene
FT-0652398
34135-85-8
A822088
3-(methyltrisulfanyl)-1-propene
unii-983o8zl28a
983o8zl28a ,
allyl methyl trisulfide [fhfi]
methyl allyl trisulfide [mi]
SCHEMBL534079
JGMPRNFEEAJLAJ-UHFFFAOYSA-N
methyl allyl trisulphide
1-methyl-3-(prop-2-en-1-yl)trisulfane
DTXSID30187717
4,5,6-trithia-1-heptene
Q27272080
CS-0163777
HY-134900
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (16.67)29.6817
2010's7 (58.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.39 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]